Strain Specific Variations in Acinetobacter baumannii Complement Sensitivity
Issued Date
2022-06-22
Resource Type
eISSN
16643224
Scopus ID
2-s2.0-85133810803
Pubmed ID
35812377
Journal Title
Frontiers in Immunology
Volume
13
Rights Holder(s)
SCOPUS
Bibliographic Citation
Frontiers in Immunology Vol.13 (2022)
Suggested Citation
Kamuyu G., Ercoli G., Ramos-Sevillano E., Willcocks S., Kewcharoenwong C., Kiratisin P., Taylor P.W., Wren B.W., Lertmemongkolchai G., Stabler R.A., Brown J.S. Strain Specific Variations in Acinetobacter baumannii Complement Sensitivity. Frontiers in Immunology Vol.13 (2022). doi:10.3389/fimmu.2022.853690 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/84969
Title
Strain Specific Variations in Acinetobacter baumannii Complement Sensitivity
Other Contributor(s)
Abstract
The complement system is required for innate immunity against Acinetobacter baumannii, an important cause of antibiotic resistant systemic infections. A. baumannii strains differ in their susceptibility to the membrane attack complex (MAC) formed from terminal complement pathway proteins, but the reasons for this variation remain poorly understood. We have characterized in detail the complement sensitivity phenotypes of nine A. baumannii clinical strains and some of the factors that might influence differences between strains. Using A. baumannii laboratory strains and flow cytometry assays, we first reconfirmed that both opsonization with the complement proteins C3b/iC3b and MAC formation were inhibited by the capsule. There were marked differences in C3b/iC3b and MAC binding between the nine clinical A. baumannii strains, but this variation was partially independent of capsule composition or size. Opsonization with C3b/iC3b improved neutrophil phagocytosis of most strains. Importantly, although C3b/iC3b binding and MAC formation on the bacterial surface correlated closely, MAC formation did not correlate with variations between A. baumannii strains in their levels of serum resistance. Genomic analysis identified only limited differences between strains in the distribution of genes required for serum resistance, but RNAseq data identified three complement-resistance genes that were differentially regulated between a MAC resistant and two MAC intermediate resistant strains when cultured in serum. These data demonstrate that clinical A. baumannii strains vary in their sensitivity to different aspects of the complement system, and that the serum resistance phenotype was influenced by factors in addition to the amount of MAC forming on the bacterial surface.